IPW
IART icon

IronBridge Private Wealth’s Integra LifeSciences IART Stock Holding History

IronBridge Private Wealth’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-191
Closed -$13K – 153
2021
Q4 		$13K Hold
191
– – 0.01% 158
2021
Q3 		$13K Hold
191
– – 0.01% 131
2021
Q2 		$13K Hold
191
– – 0.01% 136
2021
Q1 		$13K Sell
191
-47
-20% -$3.18K 0.01% 132
2020
Q4 		$15K Buy
+238
New +$12.8K 0.01% 114

Other funds holding IART

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

IronBridge Private Wealth's IART Position: Q1 2022 in Review

IronBridge Private Wealth sold out of Integra LifeSciences (IART) in Q1 2022, closing a stake of 191 shares — an estimated $13K sold.

IronBridge Private Wealth first reported a position in IART in Q4 2020 and held it in 5 quarters. The position peaked at $15K in Q4 2020. 278 funds tracked by Wall St. Rank hold IART as of Q1 2022.

  • IronBridge Private Wealth reported no remaining Integra LifeSciences position as of Q1 2022 after selling out during the quarter.
  • IronBridge Private Wealth sold 191 Integra LifeSciences shares in Q1 2022, an estimated $13K.
  • IronBridge Private Wealth first reported a position in Integra LifeSciences in Q4 2020 and held it in 5 quarters.
  • IronBridge Private Wealth's Integra LifeSciences position peaked at $15K in Q4 2020.
  • 278 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2022.

Based on IronBridge Private Wealth's 13F filing for Q1 2022, filed 16 May 2022.